China Biopharmaceutical: The Phase III registered clinical trial of TQC2731 injection “TSLP monoclonal antibody” for maintenance treatment of chronic sinusitis with nasal polyps completed the enrollment of all participants.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.